GAVI Alliance on Track to Immunise a Quarter of a Billion Children by 2015 and Prevent Nearly 4 Million Deaths

GAVI Alliance on Track to Immunise a Quarter of a Billion Children by 2015 and 
Prevent Nearly 4 Million Deaths 
GENEVA, Oct. 14, 2013 /CNW/ - 
Report tracks GAVI's performance and challenges towards 2015 goals 
The GAVI Alliance is on track to meet its ambitious targets of supporting 
developing countries to immunise an additional quarter of a billion children 
by 2015, and preventing nearly four million deaths in the process. That's the 
conclusion of the Mid-Term Review report, a comprehensive and transparent 
assessment published today aimed at examining the progress GAVI has made 
midway through its current strategic period from 2011 to 2015, and the 
challenges it faces in meeting its commitments to developing countries and to 
donors. 
"GAVI is reaching record numbers of children with life-saving vaccines, just 
over two years after our successful pledging conference and midway through our 
current strategy period," said Dagfinn Høybråten, Chair of the GAVI Alliance 
Board. "More countries than ever are introducing new vaccines, resulting in 
more deaths averted and improved health and wellbeing for millions of people." 
In addition to reaching its goal of helping developing countries immunise 243 
million children between 2011 and 2015, GAVI is also on target to help avert 
nearly four million future deaths during the same period. The report also 
found that the historic gap in access to immunisation between low- and 
high-income countries is starting to close. In the Kilifi district of Kenya, 
for example, the number of hospital admissions of children with pneumococcal 
disease from vaccine serotypes fell from 38 to zero within less than three 
years of the introduction of pneumococcal vaccine. 
Such accounts have been captured in a series impact stories that are being 
published on the GAVI website alongside the report. These show the 
extraordinary efforts of implementing countries and Alliance members to ensure 
vaccines reach the children who need them, wherever they live. Together, the 
report and the impact stories, come mid-way through GAVI's funding cycle, 
following its first ever pledging conference in London, in 2011, where GAVI 
raised additional funding to enable it to commit a total of US$ 7.4 billion 
towards its mission. 
The report is being published two weeks before GAVI partners - including the 
World Health Organization, UNICEF, the World Bank, the Bill & Melinda Gates 
Foundation, implementing and donor countries, civil society organisations and 
vaccine manufacturers - meet in Stockholm for the Alliance's Mid-Term Review. 
Hosted by Hillevi Engström, Sweden's Minister for International Development 
Cooperation and HE John Dramani Mahama, President of Ghana, more than 150 
participants will discuss GAVI's progress and challenges, as laid out in this 
report, which also shows that GAVI has made significant strides towards 
achieving its four strategic goals. 
These goals include: accelerating the uptake and use of under-used and new 
vaccines; strengthening health systems to improve immunisation coverage; 
improving long-term predictability and stability of immunisation financing; 
and helping to improve vaccine market conditions for developing countries. 
According to the report, progress has been made in the following areas: 
1. Since 2011, GAVI has funded a total of 67 new vaccine 


     introductions and campaigns. By 2014 all 73 GAVI-supported
     countries will have introduced 5-in-1 pentavalent vaccines,
     including introductions in Haiti, Myanmar, Somalia and South


 Sudan.
  2. Following a slow start, GAVI's recently revamped health system 


     strengthening programme now ensures that investments are
     translated more clearly into improved immunisation outcomes. As a
     result, GAVI is seeing investments and improvements in health


 system rapidly picking up speed.
  3. GAVI is close to achieving its target of timely receipt of 100% of 


     co-financing payments (contributions made by developing countries
     towards the cost of the vaccines). As of August, 64 of the 67
     co-financing countries had fulfilled their commitments for 2012.
     And from 2011 to 2013 these payments totalled US$ 125 million,
     representing 8% of GAVI's total support to these countries. All
     this is also helping to drive increases in country investment in


 their own health systems.
  4. GAVI has also helped to produce more predictability and 


     competition in the vaccine market, which has helped to bring down
     the cost of fully vaccinating a child with three priority vaccines
     - pentavalent, pneumococcal and rotavirus - from US$ 35 in 2010 to
     US$ 23 in 2012.

The report also highlights the challenges that the Alliance is attempting to 
address. These include improving the reliability of supply chains and finding 
ways to improve in-country data collection; adopting tailored approaches to 
meet the unique and challenging needs of fragile states; and ensuring the 
sustainability of immunisation programmes in countries whose wealth has 
increased to the point that they are no longer eligible for GAVI support.

"Increasing vaccine launches is just the start of the journey. As more 
countries introduce powerful new vaccines the challenge shifts to increasing 
and sustaining immunisation coverage and making it more equitable," said Dr 
Seth Berkley, CEO of the GAVI Alliance. "Vaccines are already widely 
recognised as one of the most-cost effective public health tools, but we 
cannot rest until all children, regardless of where they live, have access to 
the best possible protection against vaccine-preventable diseases. That means 
access to all 11 of the vaccines that the WHO recommends every child should 
have. Every child deserves a healthy future."

For an online version of the report please visit: 
http://midtermreview.gavialliance.org

To read the impact stories please visit GAVI's homepage: 
http://www.gavialliance.org

GAVI Alliance

The GAVI Alliance is a public-private partnership committed to saving 
children's lives and protecting people's health by increasing access to 
immunisation in developing countries. The Alliance brings together developing 
country and donor governments, the World Health Organization, UNICEF, the 
World Bank, the vaccine industry, technical agencies, civil society, the Bill 
& Melinda Gates Foundation and other private sector partners. GAVI uses 
innovative finance mechanisms, including co-financing by recipient countries, 
to secure sustainable funding and adequate supply of quality vaccines. Since 
2000, GAVI has financed the immunisation of an additional 370 million children 
and prevented more than 5.5 million premature deaths. Learn more at 
http://www.gavialliance.org and connect with us on Facebook and Twitter.

GAVI is funded by governments [Australia, Canada, Denmark, France, Germany, 
Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Republic of Korea, 
Russia, South Africa, Spain, Sweden, United Kingdom, United States], the 
European Commission, the Bill & Melinda Gates Foundation, as well as private 
and corporate partners [Absolute Return for Kids, Anglo American plc., The 
Children's Investment Fund Foundation, Comic Relief, Dutch Postcode Lottery, 
His Highness Sheikh Bin Zayed Al Nahyan, JP Morgan, "la Caixa" Foundation, LDS 
Charities, Lions Clubs, OPEC and Vodafone].



SOURCE  GAVI Alliance 
Media Contact: Dan Thomas, Tel: +41-22-909-6524, Cell: 
+41-79-251-8581,dthomas@gavialliance.org 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/October2013/14/c9694.html 
CO: GAVI Alliance
NI: HEA * HEA  
-0- Oct/14/2013 08:52 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.